Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas

Overview of attention for article published in BMC Cancer, November 2010

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 156 Dimensions

Readers on

mendeley: 31 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

GEMCITABINE DERIVATIVES FOR CANCER THERAPY

Application WO-2018175323-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.